View in EDS HTML Full Text PDF Full Text

Clinical pharmacology and tolerability of REC‐994, a redox‐cycling nitroxide compound, in randomized phase 1 dose‐finding studies.

Saved in:
Bibliographic Details
Title: Clinical pharmacology and tolerability of REC‐994, a redox‐cycling nitroxide compound, in randomized phase 1 dose‐finding studies.
Authors: Alfa, Ron1 (AUTHOR), Considine, Timothy1 (AUTHOR), Virani, Shafique1 (AUTHOR), Pfeiffer, Matt1 (AUTHOR), Donato, Anthony2 (AUTHOR), Dickerson, Daniel3 (AUTHOR), Shuster, Diana1 (AUTHOR), Ellis, Joel1 (AUTHOR), Rushton, Kristen1 (AUTHOR), Wei, Helen1 (AUTHOR), Gibson, Christopher1 (AUTHOR) christopher.gibson@recursionpharma.com
Source: Pharmacology Research & Perspectives. Jun2024, Vol. 12 Issue 3, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20521707
DOI:10.1002/prp2.1200